Wen‐Hsing Lin

1.5k total citations
45 papers, 987 citations indexed

About

Wen‐Hsing Lin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Wen‐Hsing Lin has authored 45 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Oncology and 15 papers in Cell Biology. Recurrent topics in Wen‐Hsing Lin's work include Microtubule and mitosis dynamics (13 papers), Cancer-related Molecular Pathways (11 papers) and Cancer therapeutics and mechanisms (6 papers). Wen‐Hsing Lin is often cited by papers focused on Microtubule and mitosis dynamics (13 papers), Cancer-related Molecular Pathways (11 papers) and Cancer therapeutics and mechanisms (6 papers). Wen‐Hsing Lin collaborates with scholars based in Taiwan, India and United States. Wen‐Hsing Lin's co-authors include Hsing‐Pang Hsieh, Mohane Selvaraj Coumar, John Hsu, John T.-A. Hsu, Chun-Hwa Chen, Su‐Ying Wu, Yi-Yu Ke, Tzu‐Wen Lien, Yu-Sheng Chao and Jian-Sung Wu and has published in prestigious journals such as PLoS ONE, Cancer Research and Analytical Biochemistry.

In The Last Decade

Wen‐Hsing Lin

44 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen‐Hsing Lin Taiwan 19 569 260 212 143 111 45 987
Butrus Atrash United Kingdom 18 767 1.3× 323 1.2× 260 1.2× 178 1.2× 90 0.8× 39 1.2k
Manuela Gridling Austria 13 672 1.2× 269 1.0× 126 0.6× 61 0.4× 47 0.4× 17 1.0k
Philip Lienau Germany 21 766 1.3× 468 1.8× 433 2.0× 188 1.3× 43 0.4× 37 1.4k
Robert A. Galemmo United States 19 494 0.9× 158 0.6× 262 1.2× 53 0.4× 143 1.3× 46 1.0k
Ana Negri Spain 18 649 1.1× 119 0.5× 146 0.7× 44 0.3× 130 1.2× 31 1.1k
Zhuang Yang China 23 680 1.2× 253 1.0× 680 3.2× 51 0.4× 72 0.6× 61 1.3k
Linda Rickardson Sweden 18 705 1.2× 290 1.1× 82 0.4× 103 0.7× 55 0.5× 28 1.1k
Yongxia Zhu China 20 798 1.4× 313 1.2× 170 0.8× 52 0.4× 48 0.4× 64 1.3k
Veeraswamy Manne United States 23 1.1k 1.9× 441 1.7× 183 0.9× 195 1.4× 63 0.6× 37 1.5k
Yali Deng China 9 479 0.8× 240 0.9× 236 1.1× 77 0.5× 24 0.2× 13 802

Countries citing papers authored by Wen‐Hsing Lin

Since Specialization
Citations

This map shows the geographic impact of Wen‐Hsing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Hsing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Hsing Lin more than expected).

Fields of papers citing papers by Wen‐Hsing Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen‐Hsing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Hsing Lin. The network helps show where Wen‐Hsing Lin may publish in the future.

Co-authorship network of co-authors of Wen‐Hsing Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Hsing Lin. A scholar is included among the top collaborators of Wen‐Hsing Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Hsing Lin. Wen‐Hsing Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Haijing, Wen‐Hsing Lin, Xiaodan Ma, et al.. (2025). A timecourse analysis of gonadal histology and transcriptome during the sexual development of yellow catfish, Pelteobagrus fulvidraco. Comparative Biochemistry and Physiology Part D Genomics and Proteomics. 56. 101576–101576.
2.
Li, Mu‐Chun, J. Satyanarayana Reddy, Chih‐Ming Chen, et al.. (2024). Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment. Journal of Medicinal Chemistry. 67(13). 10906–10927. 3 indexed citations
3.
Yen, Wan-Ching, Wen‐Hsing Lin, Yu‐Chieh Su, et al.. (2021). Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model. Journal of Medicinal Chemistry. 64(19). 14477–14497. 30 indexed citations
4.
Li, Mu‐Chun, Wen‐Hsing Lin, Yu‐Chieh Su, et al.. (2021). Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimization. European Journal of Medicinal Chemistry. 224. 113673–113673. 13 indexed citations
5.
Lin, Shu‐Yu, Yi-Yu Ke, Wen‐Hsing Lin, et al.. (2019). Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer. Journal of Medicinal Chemistry. 62(22). 10108–10123. 30 indexed citations
6.
Ke, Yi‐Yu, Chun‐Ping Chang, Wen‐Hsing Lin, et al.. (2018). Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition. European Journal of Medicinal Chemistry. 151. 533–545. 10 indexed citations
7.
Lin, Wen‐Hsing, Yi-Yu Ke, Chun-Hwa Chen, et al.. (2016). Discovery of novel inhibitors of Aurora kinases with indazole scaffold: In silico fragment-based and knowledge-based drug design. European Journal of Medicinal Chemistry. 124. 186–199. 19 indexed citations
8.
Chen, Chiung-Tong, John T.-A. Hsu, Wen‐Hsing Lin, et al.. (2015). Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations. European Journal of Medicinal Chemistry. 100. 151–161. 8 indexed citations
9.
Ke, Yi-Yu, Vivek Kumar Singh, Mohane Selvaraj Coumar, et al.. (2015). Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification. Scientific Reports. 5(1). 11702–11702. 64 indexed citations
10.
Ke, Yi-Yu, Mohane Selvaraj Coumar, Hui-Yi Shiao, et al.. (2014). Ligand efficiency based approach for efficient virtual screening of compound libraries. European Journal of Medicinal Chemistry. 83. 226–235. 14 indexed citations
11.
Lin, Wen‐Hsing, Teng‐Kuang Yeh, Weir‐Torn Jiaang, et al.. (2014). Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer. PLoS ONE. 9(1). e83160–e83160. 19 indexed citations
12.
Sarvagalla, Sailu, Vivek Kumar Singh, Yi-Yu Ke, et al.. (2014). Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for Aurora kinase A selectivity. Journal of Computer-Aided Molecular Design. 29(1). 89–100. 38 indexed citations
13.
Ke, Yi‐Yu, Chang‐Ying Chu, Yen‐Chun Lee, et al.. (2012). 3D‐QSAR‐Assisted Drug Design: Identification of a Potent Quinazoline‐Based Aurora Kinase Inhibitor. ChemMedChem. 8(1). 136–148. 23 indexed citations
14.
Lin, Wen‐Hsing, Shih-Chieh Yen, Chiung‐Tong Chen, et al.. (2011). Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3). Bioorganic & Medicinal Chemistry. 19(14). 4173–4182. 14 indexed citations
15.
Lin, Wen‐Hsing, et al.. (2011). BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML. British Journal of Cancer. 106(3). 475–481. 11 indexed citations
16.
Jiang, Yi-Der, Yi‐Cheng Chang, Yen‐Feng Chiu, et al.. (2010). SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10and PAD in type 2 diabetes. BMC Medical Genetics. 11(1). 126–126. 13 indexed citations
17.
Lin, Wen‐Hsing, Jen‐Shin Song, Chunyu Chang, et al.. (2008). A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors. Analytical Biochemistry. 377(1). 89–94. 8 indexed citations
18.
Wu, Yu-Shan, Wen‐Hsing Lin, John Hsu, & Hsing‐Pang Hsieh. (2006). Antiviral Drug Discovery Against SARS-CoV. Current Medicinal Chemistry. 13(17). 2003–2020. 36 indexed citations
19.
Lin, Wen‐Hsing, et al.. (2006). Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population. Diabetologia. 49(6). 1214–1221. 19 indexed citations
20.
Lin, Wen‐Hsing, et al.. (2002). Identification of Differentially Expressed Genes During Adipocyte Differentiation and the Effect of Rosiglitazone on Adipocyte Gene Expression. 13(1). 28–43. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Butrus Atrash Breakdown of academic impact, for papers by Manuela Gridling Breakdown of academic impact, for papers by Philip Lienau Breakdown of academic impact, for papers by Robert A. Galemmo Breakdown of academic impact, for papers by Ana Negri Breakdown of academic impact, for papers by Zhuang Yang Breakdown of academic impact, for papers by Linda Rickardson Breakdown of academic impact, for papers by Yongxia Zhu Breakdown of academic impact, for papers by Veeraswamy Manne Breakdown of academic impact, for papers by Yali Deng
Rankless by CCL
2026